475 related articles for article (PubMed ID: 20303034)
21. Impact of intraoperative high-volume autologous blood collection on allogeneic transfusion during and after cardiac surgery: a propensity score matched analysis.
Henderson RA; Mazzeffi MA; Strauss ER; Williams B; Wipfli C; Dawood M; Taylor BS; Tanaka KA
Transfusion; 2019 Jun; 59(6):2023-2029. PubMed ID: 30882929
[TBL] [Abstract][Full Text] [Related]
22. [Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety].
Cazenave JP
Bull Acad Natl Med; 2010 Dec; 194(9):1707-19; discussion 1719-20. PubMed ID: 22043595
[TBL] [Abstract][Full Text] [Related]
23. Zika Virus and Patient Blood Management.
Goodnough LT; Marques MB
Anesth Analg; 2017 Jan; 124(1):282-289. PubMed ID: 27902502
[TBL] [Abstract][Full Text] [Related]
24. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
Valeri CR; Ragno G
Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
[TBL] [Abstract][Full Text] [Related]
25. Efforts Toward Elimination of Infectious Agents in Blood Products.
Jacquot C; Delaney M
J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
[TBL] [Abstract][Full Text] [Related]
26. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
27. Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.
Caram-Deelder C; Kreuger AL; Evers D; de Vooght KMK; van de Kerkhof D; Visser O; Péquériaux NCV; Hudig F; Zwaginga JJ; van der Bom JG; Middelburg RA
JAMA; 2017 Oct; 318(15):1471-1478. PubMed ID: 29049654
[TBL] [Abstract][Full Text] [Related]
28. Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma.
Cordes AK; Goudeva L; Lütgehetmann M; Wenzel JJ; Behrendt P; Wedemeyer H; Heim A
J Hepatol; 2022 Jan; 76(1):46-52. PubMed ID: 34461207
[TBL] [Abstract][Full Text] [Related]
29. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
Klausen SS; Hervig T; Seghatchian J; Reikvam H
Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
[TBL] [Abstract][Full Text] [Related]
30. Blood transfusion risks and alternative strategies in pediatric patients.
Lavoie J
Paediatr Anaesth; 2011 Jan; 21(1):14-24. PubMed ID: 21155923
[TBL] [Abstract][Full Text] [Related]
31. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
32. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
33. Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization.
Bordin JO; Bardossy L; Blajchman MA
Transfusion; 1993 Oct; 33(10):798-801. PubMed ID: 8236419
[TBL] [Abstract][Full Text] [Related]
34. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
[TBL] [Abstract][Full Text] [Related]
36. ABO-incompatible platelets are associated with increased transfusion reaction rates.
Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
[TBL] [Abstract][Full Text] [Related]
37. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
38. Perioperative blood transfusions in orthopaedic surgery.
Ponnusamy KE; Kim TJ; Khanuja HS
J Bone Joint Surg Am; 2014 Nov; 96(21):1836-44. PubMed ID: 25378512
[TBL] [Abstract][Full Text] [Related]
39. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
40. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
